NASDAQ:AVXL
Anavex Life Sciences Corp.
- Stock
Last Close
7.40
06/11 22:14
Market Cap
391.04M
Beta: 0.75
Volume Today
740.90K
Avg: 1.09M
PE Ratio
−8.31
PFCF: −16.52
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -1.32M - | -1.32M 0% | ||||||||||
average payables | 1.76M - | 3.76M 113.22% | 4.36M 16.19% | 4.28M 1.88% | 4.07M 4.88% | 6.97M 71.22% | 6.94M 0.52% | |||||
average receivables | 38.42K - | 78.09K 103.26% | 44.55K 42.96% | 24.96K 43.97% | 1.34M 5,274.54% | 3.75M 179.25% | 6.99M 86.68% | 6.16M 11.85% | 2.95M 52.13% | 2.58M 12.60% | 1.22M 52.52% | |
book value per share | 0.69 - | 0.18 73.96% | 0.59 230.94% | 0.46 22.73% | 0.41 9.59% | 0.47 12.81% | 2.16 361.65% | 1.85 14.25% | 1.78 4.04% | 1.44 18.96% | 1.11 22.80% | |
capex per share | ||||||||||||
capex to depreciation | ||||||||||||
capex to operating cash flow | ||||||||||||
capex to revenue | ||||||||||||
cash per share | 0.82 - | 0.26 68.24% | 0.67 157.10% | 0.51 23.57% | 0.45 11.66% | 0.50 10.80% | 2.18 333.56% | 1.94 11.00% | 1.89 2.40% | 1.58 16.33% | 1.20 24.06% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.01 - | |||||||||||
debt to equity | 0.01 - | |||||||||||
dividend yield | ||||||||||||
earnings yield | -0.12 - | -0.12 0.03% | -0.08 31.07% | -0.15 90.29% | -0.17 12.31% | -0.10 41.67% | -0.03 69.52% | -0.06 99.79% | -0.09 50.33% | -0.09 0.19% | ||
enterprise value | 89.61M - | 118.42M 32.15% | 141.64M 19.61% | 92.28M 34.85% | 132.36M 43.43% | 235.54M 77.95% | 1.10B 367.38% | 644.55M 41.45% | 371.58M 42.35% | 341.91M 7.99% | 656.50M 92.01% | |
enterprise value over ebitda | -7.40 - | -7.87 6.37% | -9.10 15.56% | -4.82 47.00% | -4.58 4.97% | -7.58 65.45% | -26.41 248.34% | -12.87 51.27% | -7.82 39.21% | |||
ev to operating cash flow | -21.20 - | -12.82 39.53% | -15.71 22.52% | -7.33 53.31% | -7.14 2.59% | -11.06 54.88% | -36.23 227.45% | -26.59 26.60% | -13.37 49.71% | -11.10 17.03% | -16.81 51.53% | |
ev to sales | ||||||||||||
free cash flow per share | -0.23 - | -0.26 15.53% | -0.22 15.97% | -0.28 27.62% | -0.38 34.45% | -0.37 3.44% | -0.44 19.00% | -0.32 27.60% | -0.35 10.50% | -0.37 6.00% | -0.46 24.01% | |
free cash flow yield | -0.04 - | -0.07 79.50% | -0.05 26.32% | -0.11 104.78% | -0.12 9.77% | -0.08 32.94% | -0.02 69.84% | -0.03 25.93% | -0.05 74.10% | -0.06 22.24% | -0.05 20.86% | |
graham net net | 0.68 - | 0.17 74.77% | 0.58 239.18% | 0.43 26.89% | 0.36 14.77% | 0.44 20.73% | 2.12 382.88% | 1.84 13.42% | 1.76 4.16% | 1.42 19.24% | 1.10 22.82% | |
graham number | 3.18 - | 1.30 59.07% | 2.10 61.30% | 2.01 4.27% | 2.24 11.52% | 2.18 2.66% | 5.14 135.62% | 5.10 0.75% | 4.88 4.31% | 4.09 16.25% | ||
income quality | 0.35 - | 0.63 79.54% | 0.67 6.88% | 0.72 7.61% | 0.70 2.26% | 0.81 14.96% | 0.80 1.05% | 0.51 36.97% | 0.58 15.78% | 0.72 22.51% | 0.84 17.50% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -98.97 - | -1.31 98.67% | -57.44 - | -49.27 14.22% | ||||||||
interest debt per share | 0.01 - | 0.32 3,702.97% | 0.01 - | 0.01 1.87% | ||||||||
inventory turnover | ||||||||||||
invested capital | 0.01 - | 120.26M - | 97.52M 18.91% | |||||||||
market cap | 104.82M - | 127.61M 21.74% | 169.08M 32.50% | 115.21M 31.86% | 154.54M 34.14% | 264.79M 71.33% | 1.25B 373.20% | 793.71M 36.65% | 522.61M 34.16% | 474.10M 9.28% | 759.08M 60.11% | |
net current asset value | 12.81M - | 6.26M 51.16% | 24.20M 286.87% | 20.44M 15.55% | 20.29M 0.73% | 27.24M 34.24% | 150.82M 453.73% | 142.49M 5.52% | 141.85M 0.45% | 120.26M 15.22% | 93.63M 22.14% | |
net debt to ebitda | 1.26 - | 0.61 51.37% | 1.76 188.57% | 1.20 32.02% | 0.77 35.90% | 0.94 22.57% | 3.65 287.59% | 2.98 18.39% | 3.18 6.76% | |||
net income per share | -0.65 - | -0.42 35.66% | -0.33 21.38% | -0.39 18.59% | -0.54 37.56% | -0.45 16.01% | -0.54 20.26% | -0.62 14.87% | -0.60 4.58% | -0.52 13.44% | ||
operating cash flow per share | -0.23 - | -0.26 15.53% | -0.22 15.97% | -0.28 27.62% | -0.38 34.45% | -0.37 3.44% | -0.44 19.00% | -0.32 27.60% | -0.35 10.50% | -0.37 6.00% | -0.46 24.01% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -0.78 - | -1.55 98.22% | -0.48 68.83% | -0.72 48.08% | -1.04 44.99% | -0.76 26.71% | -0.23 69.17% | -0.31 33.95% | -0.31 2.09% | -0.32 3.12% | ||
revenue per share | ||||||||||||
roe | -0.95 - | -2.34 147.14% | -0.55 76.24% | -0.85 53.47% | -1.30 52.16% | -0.96 25.55% | -0.25 73.95% | -0.34 33.96% | -0.33 0.57% | -0.36 6.80% | ||
roic | -0.55 - | -2.36 326.11% | -0.64 72.77% | -0.94 46.09% | -1.42 51.20% | -1.13 20.49% | -0.28 75.23% | -0.38 37.40% | -0.33 12.96% | |||
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 0.69 - | 0.18 73.96% | 0.59 230.94% | 0.46 22.73% | 0.41 9.59% | 0.47 12.81% | 2.16 361.65% | 1.85 14.25% | 1.78 4.04% | 1.44 18.96% | 1.11 22.80% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 12.81M - | 6.31M 50.75% | 24.25M 284.49% | 20.49M 15.51% | 20.29M 0.98% | 27.24M 34.24% | 150.82M 453.73% | 142.49M 5.52% | 141.85M 0.45% | 120.26M 15.22% | 94.87M 21.12% | |
tangible book value per share | 0.69 - | 0.18 73.96% | 0.59 230.94% | 0.46 22.73% | 0.41 9.59% | 0.47 12.81% | 2.16 361.65% | 1.85 14.25% | 1.78 4.04% | 1.44 18.96% | 1.11 22.80% | |
working capital | 12.81M - | 6.26M 51.16% | 24.20M 286.87% | 20.44M 15.55% | 20.29M 0.73% | 27.24M 34.24% | 150.82M 453.73% | 142.49M 5.52% | 141.85M 0.45% | 120.26M 15.22% | 97.52M 18.91% |
All numbers in USD (except ratios and percentages)